Products containing the blood pressure drug valsartan, withdrawn from the U.S. and European markets because some lots were tainted with possible carcinogens, are not associated with a markedly increased short term risk of cancer, according to an expedited analysis. The findings were published in The BMJ. At the same time, the authors say further studies… Continue reading Recalled Blood-Pressure Pill Shows No Short-Term Risk of Cancer